Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SC-CAR4BRAIN |
Synonyms | |
Therapy Description |
Limited information is currently available on SC-CAR4BRAIN, a putative chimeric antigen receptor (CAR) T-cell therapy targeting B7-H3, EGFR, ERBB2 (HER2), and IL-13-zetakine (Apr 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SC-CAR4BRAIN | Limited information is currently available on SC-CAR4BRAIN, a putative chimeric antigen receptor (CAR) T-cell therapy targeting B7-H3, EGFR, ERBB2 (HER2), and IL-13-zetakine (Apr 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05768880 | Phase I | SC-CAR4BRAIN | Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors | Recruiting | USA | 0 |